9
Views
3
CrossRef citations to date
0
Altmetric
Review

Evaluation of radiotherapy for pediatric CNS tumors

Pages 491-500 | Published online: 10 Jan 2014

References

  • Halperin E, Constine L, Tarbell N, Kun L. Pediatric Radiation Oncology Mild Edition Lippincott Williams and Wilkins, PA, USA, 37–79 (1999).
  • Finlay J. Chemotherapy for childhood brain tumors: an appraisal for the millenium. Child Nerv Syst 15,496–497 (1999).
  • Loeffler J, Kooy H, Tarbell N. The emergence of conformal radiotherapy: special implications for pediatric neuro-oncology. Int. J Rad. Oncol Biol. Phys. 44 (2), 237–238 (1999).
  • Skowronska-Gardas A, Morawska- Kaczy_ska M. Conformal radiotherapy in paediatric brain tumours. In: Progness in Radio Oncology VI, Monduzzi Editore, Bolgna, Italy, 639–643 (1998).
  • Adams E, Suter B, Warrington A, Black P, Saran F, Brada M. Design and implementation of a system for treating pediatric patients with stereotactically-guided conformal radiotherapy. Radiother. Oncol 60,289–297 (2001).
  • Freeman C, Farmer J-P, Montes J. Low- grade astrocytomas in children: evolving management strategies. Int. J Rad. Oncol Biol. Phys. 41(5), 979–987 (1998). Provides a good review of the management strategies in low-grade astrocytoma in children.
  • Fisher B, Leighton C, Vujovic O, Macdonald D, Stitt L. Results of a policy of surveillance alone after surgical management of pediatric low-grade gliomas. Int. J Rad Oncol Biol. Phyc 51(3), 704–710 (2001).
  • Debus I. Kocagonca O, Höss A, Wenz F, Wannenmacher M. Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int. Rad. Oncol Biol. Phys. 44(2), 243–248 (1999).
  • Grabenauer G, Schuchardt U, Buchfelder M et al Radiation therapy of optic-hypothalamic gliomas (OHG)-radiographic response, vision and late toxicity. Radioth. Oncol 54(3), 239–245 (2000).
  • Gropman A, Packer R, Nicolson S et al. Treatment of Diencephalic Syndrome with Chemotherapy. Cancer 83(1), 166–172 (1998).
  • Bouffet E, Pierre-Kahn A, Marshal JC et al Prognostic factors in pediatric spinal cord astrocytoma. Cancer 83 (11), 2391–2399 (1998).
  • Rodrigues G, Waldorn J, Wong S, Laperriere N. A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy. Int. J Rad Oncol Phys. 48(3), 837–842 (2000).
  • Campbell JVV, Pollock JF,Martinez AJ et al Radiologically complete resection is associated with excellent long-term prognosis. Neurosurgei y38, 258–264 (1996).
  • Skowrofiska-Gardas MA. Badania nad skutecznoscia radioterapii nowotworów osrodkowego uldadu nerwowoego u dzieci. (Efficiency of radiotherapy of central nervous system tumors in children). Nowotwory 49,289–300 (1999).
  • Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M. 3D recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother. Oncol 53(1), 53–57 (1999).
  • Fallai C, Olmi P Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors and brain metastases). Radiother. Oncol 43(3), 235–246 (1997).
  • ••Good review of hyperfractionated andaccelerated therapy applied in the treratment of CNS tumors.
  • Pollack I, Boyett J, Finlay J. Chemotherapy for high-grade gliomas of childhood. Child Nerv. Syst. 15,529–544 (1999).
  • Freeman C, Farmer JR Pediatric brain stem gliomas: a review. Int. J. Rad. Oncol Biol. Phys. 40(2), 265–271 (1998).
  • •Good review of the treatment recommendations for pediatric brain stem glioma.
  • Donanue B, Allen J, Siffert J, Rosovsky M, Pinto R. Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination. Int. J. Rad. Oncol Biol. Phys. 40(3), 677–680 (1998).
  • Skowronska-Gardas A. Hyperfractionated radiotherapy for brain-stem tumors in children. Radiother. Oncol 33,259–261 (1994).
  • Mandell L, Kadota R, Freeman C et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brain stem tumors: results of a Pediatric Oncology Group Phase III trial comparing conventional versus hyperfractionated radiotherapy. Int. J. Rad. Oncol Biol. Phys. 43(5), 959–964 (1999) .
  • •Important article showing results of randomized trial Pediatric Oncology Group comparing conventional versus hypofractionated radiotherapy for pediatric brain stem tumors.
  • Fischer P, Donaldson S. Hyperfractionated radiotherapy in the management of diffuse intrinsic brain stem tumors: when is enough enough? Int. J. Rad. Oncol Biol. Phys. 43(5), 947–949 (1999).
  • Allen J, Siffert J, Donahue B et al A Phase I/II Study of carboplatin complied with hyperfractionated radiotherapy for brainstem gliomas. Cancer 86 (6), 1064–1068 (1999).
  • Bouffet E, Raquin M, Doz F et al Radiotherapy followed by high dose busulfan and thiotepa. A prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88 (3), 685–692 (2000) .
  • Freeman C, Kepner J, Kun L et al A detrimental effect of a combined chemotherapy—radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int. J. Rad. Oncol Biol. Phys. 47(3), 561–564 (2000).
  • del Charco J, Bolek T, McCollough M et al Medulloblastoma: time—dose relationship based on a 30-year review. Int. J. Rad Oncol Biol. Phys. 42(1), 147–154 (1998).
  • Freeman C, Taylor R, Kortman RD, Carrie C. Radiotherapy for medulloblastoma in children: a prospective on current international clinical research efforts. Med. Fed. Oncol 39,99–108 (2002).
  • ••Good review of current internationalclinical research efforts in medulloblastoma.
  • Agranovich A, Al-Ghazi M, Swift C, Kwan W CT-based 3D planning of craniospinal radiotherapy. Progress in Radio-Oncology VI. Monduzzi Editore, Bologne, Italy, 619–625 (1998).
  • Halperin E. Impact of radiation technique upon the outcome of treatment for medulloblastoma. Int. J. Rad Oncol Biol. Phys. 36,233–239 (1996).
  • •Shows the impact of radiation technique upon the outcome of treatment for medulloblastoma.
  • Grabenauer G, Beck J, Erhardt J et al. Postoperative radiotherapy of medulloblastoma. Impact of radiation quality on treatment outcome. Am. J. Clin. Oncol 19,73–77 (1996).
  • Mirabell R, Bleher A, Huegenin P et al Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int. Rad Oncol Biol. Phys. 37,523–529 (1997).
  • Fukunaga-Johnson N, Sandler H, Marsh R, Martel M. The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma. Int. j Rad Chrol Biol. Phys 41,77–82 (1998).
  • Narayama A, Jeswani S, Paulino A. The craniospinal junction in medulloblastoma: does it matterikt. J. Rad. Oncol Biol. Phys. 44,81-84 (1999).
  • Scharf C, Paulino A, Goldberg K. Determination of the inferior border of the the cal sac using magnetic resonance imaging: implications on radiation therapy treatment planning. Int. J. Rad. Oncol Biol. Phys. 41,621-624 (1998).
  • Weiss E, Krebek M, Kohler B, Pradier O, Hess C. Does the standardized helmet technique lead to adequate coverage of the cribriform plate? An analysis of current practice with respect of the ICRU 50 report. Int. J. Rad Oncol Biol. Phys. 49, 1475–1480 (2001).
  • Paulino A, Narayama A, Mohideen N, Jeswani S. Posterior fossa boost in medulloblastoma an analysis of dose to surrounding structures using 3-dimentional conformal radiotherapy. Int. J. Rad Oncol Biol. Phys. 46(2), 281–286 (2000).
  • Mah K, Danjoux C, Manship S, Makhani N, Cardosso M, Sixel K Computed tomographic simulation of craniospinal fields in pediatric patient: improved treatment accuracy and patients comfort. Int. j Rad °rico'. Biol. Phys 41(5), 997–1003 (1998).
  • Halperin E, Watson D, George S. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer91, 1444–1450 (2001).
  • Paulino A, Melien E. Medulloblastoma and supratentorial primitive neuroectodermal tumors. Cancer 86(1), 142–148 (1999).
  • Zeltzer P, Boyett J, Finlay J. et al. Metastasis stage, adjuvant treatment and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized Phase III study. J. Clin. Oncol 17(3), 832–845 (1999).
  • Allen J, Donahue B, Da Rosso R, Nisenberg A. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int. J. Rad Oncol Biol. Phys. 36(5), 1155–1161 (1996).
  • Rados M. Edwards M, Chang S et al Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Int. J Rad. Oncol. Biol. Thj3. 43(2), 279–285 (1999).
  • Kun L. Medulloblastoma — challenges in radiation therapy and the addition of chemotherapy. Int. J. Rad. Oncol Biol. Fhys. 46(2), 261–263 (2000).
  • Packer R, Goldwein J, Nicholson H et al Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Childrens Cancer Group Study. J. Glitz °rico'. 17, 2127–2136 (1999).
  • Kortman R, Kahl J, Timmerman P et al Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT 91. Int. Rad °rico'. Biol. Phys. 46(2), 269–279 (2000).
  • Strother D, Ashley D, Kellie S et al. Feasibility of four consecutive high-dose chemotherapy cycles with stem cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J. Clin. Oncol 19(10), 2696–2704 (2001).
  • Healey EA, Braners PD, Kupley WJ et al The prognostic significance of postoperative residual tumor in ependymoma. Neutosutgery 28,666–672 (1991).
  • Mc Laughin M, Marcus R, Buatti J et al Ependymoma: results, prognostic factors and treatment recommendation. Int. J. Rad Oncol Biol. Phys. 40(4), 845–850 (1998).
  • Schild S, Nisi K, Scheithaur B et al The results or radiotherapy for ependymomas: the Mayo Clinic experience. Int. J. Rad Oncol Biol. Phys. 42(5), 953–958 (1998).
  • Timmermann B, Kortman R, Kahl J et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results on the German prospective trials HIT 88/89 and HIT 91. Int.j Rad Oiled Biol. Phys. 46(2), 287–295 (2000).
  • Paulin° A, B-Chen W The significance of radiotherapy treatment duration in intracranial ependymoma. int. J. Rad. Oncol Biol. Phys. 47(3), 585–589 (2000).
  • Khafaga Y, Jenkin D, Kanaau I et a/. Craniopharyngioma in children. int.,/ Rad. Oncol. Biol. Phys. 42(3), 601–606 (1998).
  • Habrand JL, Ganry O, Couanet D et al The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int. Rad. Oncol. Biol. Phys 44(2), 255–263 (1999).
  • Kalapurakel J, Goldman S, Hsieh Y, Tomita T, Marymout M. Clinical outcome in children with recurrent craniopharyngioma after primary surgery. Cancer6(6), 388–393 (2000).
  • Merchant T Sherwood S, Mulhem R et al CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. int./. Rad °rico'. Biol. Phys 46(5), 1171–1176 (2000).
  • Bouffet E, Baranzelli M, Patte C et al Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Br. J. Cancer 79(7/8), 1199–1204 (1999).
  • Alapetite C, Ricardi U, Saran F et al Whole ventricular irradiation in combination with chemotherapy in intracranial germinoma: the consensus of the STOP CNS CGT Study group. Med Fed. 017C0i 39,248 (2002).
  • Gajjer A, Mulhem R, Heideman R et al. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J. Clin. Oncol 12(6), 1212–1216 (1994).
  • Geyer R, Boyett J, Rorke L et al Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. Clin. Oncol 12(8), 1607–1615 (1994).
  • Fisher P, Needle M, Cnaan A et al Salvage therapy after postoperative chemotherapy for primary brain tumors in infants and very young children. Cancer 83(3), 566–574 (1998).
  • Saran F, Driever P, Thilman C et a/. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation. Int J Rad Oncol. Biol. Phys. 42(5), 959–967 (1998).
  • •Provides a review of treatment studies in medulloblastoma in very young children.
  • Skowronska-Gardas A. Radiotherapy of central nervous system tumour in young children: benefits and pitfalls. Med. Fed Oncology33, 572–576 (1999).
  • Belka C, Budach W, Kortman R, Bamberg M. Radiation induced CNS toxicity-molecular and cellular mechanisms. BE J. Cancer85(9), 1233–1239 (2001).
  • Steen C, Koury M, Grania I et al. Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. int. J. Rad Oncol Biol. Phys. 49(1), 79–91 (2001).
  • Russo C, Fischbein N, Grant C, Prados M. Late radiation injury following hyperfractionated craniospinal radiotherapy for primitive neuroectodermal tumor. int. J. Rad Oncol Biol. Phys. 44(1), 85–90 (1999).
  • Copeland D, de Moor C, Moore III B, Alter J. Neurocongnitive development of children after a cerebelar tumor in infancy: a longitudinal study. J. Clin. Oncol. 17, 3476–3486 (1999).
  • Ris D, Packer R, Goldwein J, Jones-Wallace D, Boyett J. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group Study. J. Clin. Oncol 19,3470–3476 (2001).
  • Heikens J, Michiels E, Behrendt H, Endert E, Bakker P, Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Europ. Cancer34(10), 1592–1597 (1998).
  • Chin D, Sklar C, Donahue B et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors. Cancer 80,798–804 (1997).
  • Ricard U, Corrias A, Einaudi S et al Thyroid dysfunction as late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int. .1. Rad Oncol Biol. Phys. 50(5),1287-1294 (2001).
  • Little M, de Vathaire F, Shamsaldin A eta/. Risks of brain tumor following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. hit. 1ncer78, 269–275 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.